Anterior|Siguiente

Contenido académico de la teoría de los tumores en red y su aplicación

  • role： First author第一作者
  • Affiliation：

    Guang'anmen Hospital of China Academy of Chinese Medical Sciences， Beijing 100053， China

    Beijing University of Chinese Medicine， Beijing 100029， China

  • Email：121783950@qq.com
  • Introduction：张广辉，在读博士，主治医师，从事中医防治恶性肿瘤研究，E-mail：121783950@qq.com
ZHANG Guanghui12,  
  • role： Corresponding author通信作者
  • Affiliation：

    Guang'anmen Hospital of China Academy of Chinese Medical Sciences， Beijing 100053， China

  • Email：huabaojin@sohu.com
  • Introduction：花宝金，博士，主任医师，从事中医防治恶性肿瘤研究，E-mail：huabaojin@sohu.com
HUA Baojin1*

resumen

La teoría moderna de los tumores en la medicina china se enfrenta a importantes desafíos en lo que respecta a la comprensión teórica, al diagnóstico clínico y al tratamiento, que difieren considerablemente entre sí, y a la falta de unidad y estrategias normalizadas. La terminología y el concepto extendido de las enfermedades en red tienen un valor científico diverso. El equipo hereda principios modernos de terapia en red y presenta la teoría de los tumores en red. La teoría de los tumores en red desde el punto de vista de la energía Yin y Yang destaca que la raíz del tumor en red reside en la pérdida de control de la energía Yin y Yang de la enfermedad en red, y considera al cuerpo del tumor en red dañino para la energía Yin y Yang, y expone 7 características patológicas del tumor en red (latencia oculta, enfermedad aguda, toxicidad de coagulación, facilidad de bloqueo y magulladuras, facilidad de debilidad y daño, dispersión y cambio polimorfo, diferentes viseras y redes) y 5 mecanismos patológicos específicos del tumor en red (toxicidad oculta, coagulación del tumor, fractura del tumor, anomalía del tumor, flujo tóxico del tumor). Al final, todo el mecanismo de evolución del tumor en red pasa por 4 niveles (inicio de los tumores, etapa intermedia, etapa avanzada y después del tratamiento) en todos los pacientes. En la práctica, es necesario hacer claramente la diferencia entre el estado energético de la red del paciente y el tumor de la red para maximizar la energía de la red y gobernar la energía del tumor. Sobre esta base, se proponen nuevos métodos de tratamiento del tumor en red: se regula la energía, se fomenta la regulación de la energía del tumor en red, la perturbación de la energía del tumor en red. Finalmente, se discute el valor aplicado de la teoría de los tumores en red en la realización clínica, la promoción de la investigación científica, la superación de barreras teóricas, etc. El objetivo es perfeccionar el sistema teórico del diagnóstico de tumores malignos

palabra clave

Energía del tumor Yin y Yang, terapia de tumores en red, cuerpo de tumor en red, regulación de la energía

References

  1. 1.
    YU G Q. Discussion on several issues related to the study of tumor support and foundation［J］.Chin J Integr Med，1985，5（2）：77-79.
  2. 2.
    YAN H F，LIN H S.The academic experience of Yu Guiqing［J］.Chin J Surg Integr Tradit West Med，，2001，7（3）：42-43.
  3. 3.
    GU J H，LIU J X.Professor LIU Jiaxiang's core theory and application methods of "supporting healthy Qi to treat cancer"［J］.Chin J Integr Med，2017，37（4）：495-499.
  4. 4.
    CHENG H B，WU M H. Discussion on academic thought of professor ZHOU Zhong-ying about cancerous toxin［J］.China J Tradit Chin Med Pharm，2010，25（6）：866-869.
  5. 5.
    CHEN Y Z， ZHOU R S. Discussion on the academic thoughts of survival with tumor advocated by traditional Chinese medicine master ZHOU Dai-han［J］.J Oncol Chin Med，2022，4（2）：1-5.
  6. 6.
    TANG D X，YANG Z，LIU S Y.LIU Shangyi's academic viewpoints of treating tumors as ulcer and treating tumors from membrane in diagnosis and treatment of cancer［J］.J Tradit Chin Med，2016，57（20）：1732-1734.
  7. 7.
    TAO Y，LI L，TAO L H，et al.Review of modern TCM oncology academic thought［J］.Cancer Res Prev Treat，2023，50（10）：929-934.
  8. 8.
    CHEN H B，ZHOU H G，LI L，et al.Thoughts on the development of TCM oncology［J］.Chin J Inf Tradit Chin Med，2019，26（11）：1-4.
  9. 9.
    ZHANG J，LIU Y M，PANG L J，et al.Role and significance of collateral disease discipline construction［J］.Chin Arch Tradit Chin Med，2019，37（5）：1058-1060.
  10. 10.
    WANG Q，LIN X F.Treating accumulation from the perspective of collaterals in "Essential prescriptions of the golden cabinet"［J］.Hebei J Tradit Chin Med，2014，36（5）：754-755.
  11. 11.
    WU Y L.Collateral disease theory［M］.2nd ed.Beijing：China Traditional Chinese Medicine Publishing House，2017：8-9.
  12. 12.
    TENG J，LI L，XIA J Y，et al. Exploring vascular recruitment in tracheobronchial adenoid cystic carcinoma from perspective of abnormal collateral ［J］.Chin J Exp Tradit Med Form，2025，31（6）：260-269.
  13. 13.
    CHEN Y，WU S，LIAO S N，et al.Collateral and stasis generating cancer toxin and malignant tumor［J］.China J Tradit Chin Med Pharm，2024，39（4）：2062-2065.
  14. 14.
    LI Y，PANG B，HUA B J，et al.Discussing the pathogenesis of malignant tumors based on the theory of collaterals disease［J］.J Tradit Chin Med，2022，63（15）：1427-1430.
  15. 15.
    YIN Y J，CHANG L P，WEI C.Theoretical exploration of cancer-related fatigue in malignant tumors guided by luobing theory［J］.Chin J Exp Tradit Med Form，2024，30（6）：211-217.
  16. 16.
    XU B W，LI J，GAO R K，et al.On the treatment of tumor in traditional Chinese medicine based on the theory of ''Yang transforming Qi，Yin shaping up body''［J］.J Tradit Chin Med，2020，61（4）：315-318
  17. 17.
    WU Y L，WEI C，ZHAO S S.Qi and Qi-collateral theory［J］.J Tradit Chin Med，2017，58（21）：1801-1807.
  18. 18.
    LIU X Y.Structure and attribute of the membrane and viscera system based on the thinking mode of traditional Chinese medicine： Discussion on one of the membrane and viscera system theories in traditional Chinese medicine［J］.J Hunan Univ Chin Med，2018，38（10）：1093-1098.
  19. 19.
    ZENG R H，OUYANG H G，ZHOU L，et al.The general situation of research on the relationship between meridian and lymphatic system［J］.J Basic Chin Med，2018，24（8）：1181-1183.
  20. 20.
    CHANG F Y，WANG Y Y，GAO Y，et al.Comparison between Xuanfu and cell gaps［J］.J Anhui Univ Chin Med，2005（2）：1-3.
  21. 21.
    JIN Y J，ZHAI W J W，YANG R，et al.Preliminary conception of theory of triple energizer-nutrient-defense loop［J］.Chin J Exp Tradit Med Form，2022，28（18）：213-224.
  22. 22.
    WANG X，WANG Y Y.Discussion and clinical verification for collateral vessels，diseases collateral and collateral diseases［J］.J Beijing Univ Tradit Chin Med，2015，38（9）：581-586.
  23. 23.
    XIA H M，WANG Q Q.Theoretical study on gasification theory of Huangdi Neijing［J］.China J Tradit Chin Med Pharm，2021，36（10）：5774-5776.
  24. 24.
    CHANG F Y，WANG Y Y，GAO Y，et al.Interpretation of the concept of Xuanfu （Ⅵ） - Xuanfu is the gateway for the operation of divine mechanism［J］.J Beijing Univ Tradit Chin Med，2005，（5）：12-13.
  25. 25.
    MA F，WANG Z B.Cancer， a developmental problem［J］.Chin Bulletin Life Sci，2005，（5）：61-66.
  26. 26.
    LI C X，MENG D H，CHEN Y L.CHEN Yu-long talks about unvital Qi and tumor［J］.Guiding J Tradit Chin Med and Pharmacy，2019，25（20）：19-21，28.
  27. 27.
    GUO Q J， GAO Y B，WEI H M，et al.Mechanisms of Xihuang pill on inhibiting vasculogenic mimicry of gastric cancer MGC-803 cells in tumorbearing mice by regulating HIF-1α［J］.Beijing J Tradit Chin Med，2021，40（9）：940-945.
  28. 28.
    LI J， SHI B， REN X， et al. Lung-intestinal axis， Shuangshen granules attenuate lung metastasis by regulating the intestinal microbiota and related metabolites［J］. Phytomedicine， 2024，132：155831.
  29. 29.
    MANIOTIS A J， FOLBERG R， HESS A， et al.Vascular channel formation by human melanoma cells in vivo and in vitro： Vasculogenic mimicry.［J］.Am J Pathol， 1999， 155（3）：739-752.
  30. 30.
    ANDREUCCI E，LAURENZANA A，PEPPICELLI S，et al. uPAR Controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells［J］. Oncol Res， 2022，28（9）：873-884.
  31. 31.
    ZHANG G H，HE S L，LI C H，et al.Construction on ''tumor Yin-Yang Qi transformation'' model based on Huangdi Neijing and exploration on the academic implications of the method of regulating Qi and detoxification［J］.China J Tradit Chin Med Pharm，2024，39（6）：2757-2763.
  32. 32.
    SUN L T，YU J R，ZHANG L Y，et al.Primary identification of tumor phenotype from perspective of Yin and Yang in traditional Chinese medicine［J］.J Tradit Chin Med，2019，60（12）：1030-1034.
  33. 33.
    CUI Y F，LIU Z H.Analysis of the "Yin-Yang" attributes of malignant tumors［J］.Jiangsu J Tradit Chin Med，2013，45（7）：6-7.
  34. 34.
    LING C Q.Cancerous toxin is the key pathogenic factor of malignant tumor［J］.J Integr Med，2008，（2）：111-114.
  35. 35.
    QU Y T，KANG N，SONG F L，et al.To exploree thee pathogenesis，outcome and treatmentt principles of malignant
  36. 36.
    WANG H H，SONG Y，HE F，et al.Correlation between circulating tumor cells and recurrence-metastasis of colorectal cancer based on the theory of latent pathogens［J］.J Tradit Chin Med，2024，65（19）：1983-1987.
  37. 37.
    HUA F，ZHANG D W.Research progress of integrated Chinese and Western medicine in lymph node metastasis of malignant tumor［J］.J Clin Tradit Chin Med，2021，33（5）：1007-1010.
  38. 38.
    ZHENG J W，WANG J，LI H S.Staged treatment of colorectal cancer perioperative period based on the theory of collaterals disease［J］.Mod Chin Clin Med，2023，30（1）：87-89.
  39. 39.
    CHU X L，XIE F Y，LONG S D，et al.Pathogenesis of liver metastasis from colorectal cancer： Based on collateral disease theory［J］.World J Integr Tradit West Med，2022，17（10）：1909-1912.
  40. 40.
    LI J，SHI B L，LI Y，et al.Thoughts and analysis on regulating tumor pre-metastatic niche by regulating Qi and detoxifying［J］.J Tradit Chin Med，2023，64（20）：2077-2081.
  41. 41.
    CHEN J，LIAO S N，WU S，et al.Discussing the relationship between cancer toxin-collaterals disease theory and malignant tumor vessels［J］.Tradit Chin Med Res，2023，36（11）：7-10.
  42. 42.
    XIONG L，ZHENG H G.The collaterals disease view of lung cancer［J］.J Basic Chin Med，2007（2）：86-90.
  43. 43.
    ZHENG H G，HOU W，HUA B J.The academic connotation of regulating Qi and resolving toxins method and its application in prevention and treatment of tumors［J］.J Tradit Chin Med，2022，63（21）：2023-2028，2036
  44. 44.
    ZHONG X，KANG C，TENG J，et al.A restricted view on the pathogenesis of the five-shen Zang under the xuanfu theory［J］.Tianjin J Tradit Chin Med，2023，40（1）：32-37.
  45. 45.
    SUO S Y，LIU S J，XIE W J.Discussion on the Treatment of Chest Pain from the Blood of Luoluo from the Theory of Collateral Disease［J］.J SichuanTradit Chin Med，2020，38（7）：34-38
  46. 46.
    ZHANG Y Y，XU M，LIU J Y，et al.A discussion on "Zang-Luo"［J］.J Tradit Chin Med，2013，54（21）：1801-1804.
  47. 47.
    WANG C.Theory and application research of traditional Chinese medicine warming liver treatment［D］.Nanjing：Nanjing University of Traditional Chinese Medicine，2021.
  48. 48.
    LIU Y，LYU X D，PANG L J，et al.Construction of traditional Chinese medicine differentiation and treatment system of chronic obstructive pulmonary disease under direction of collateral diseases theory［J］.Chin Arch Tradit Chin Med，2020，38（6）：79-81.
  49. 49.
    ZHANG Y，YANG L W，LI J.Treatment of differentiation gastric cancer based on core pathogenesis［J］.China J Tradit Chin Med Pharm，2020，35（1）：300-303.
  50. 50.
    HUA B J，PANG B，POU B K.Advantages and strategies of TCM in preventing and treating lung cancer［J］.Beijing J Tradit Chin Med，2022，41（5）：472-475.
  51. 51.
    ZHANG X， GUO Q， LI C， et al. Immortal time bias-corrected effectiveness of traditional Chinese medicine in non-small cell lung cancer （C-EVID）： A prospective cohort study［J］. Front Oncol，2022，12：845613.
  52. 52.
    QI R Z， HE S L， LI Y， et al. Retrospective clinical study on integrated Chinese and western medicine in treatment of limited-stage small cell lung cancer［J］. Chin J Integr Med. 2023；29（8）：675-682.
  53. 53.
    CHENG M Q， QIN Y G，SONG L R，et al. Analysis of short-term efficacy of Shuangshen Sanjie formula combined with Stupp regimen in the treatment of postoperative glioblastoma patients with Qi deficiency and blood stasis［J］.China J Tradit Chin Med Pharm，2024，39（3）：1570-1573.
  54. 54.
    LI Y Y，BAO Y J，ZHENG H G，et al.External application of Xiaozheng Zhitong Gel in the treatment of pain from bone metastasis：A randomized controlled trial［J］.J Tradit Chin Med，2022，63（24）：2353-2360.
  55. 55.
    SHI Z， HE Q Y， HUA B J. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion［J］. Chin J Integr Med， 2008，14（4）：257-261.
  56. 56.
    QI R Z，MI X，ZHAO Y W，et al.Inhibitory effects of Shuangshen granules on tumor-associated macrophages in
  57. 57.
    JIN Z C，XI Y P，ZHANG X，et al.Formation and mechanism of compound Chinese herbal medicine Xiaoshui Formula to inhibit malignant pleural effusion in mice［J］.Beijing J Tradit Chin Med，2018，37（12）：1129-1134，1221.
  58. 58.
    WANG B，GUAN J F，CAI Y，et al.Inhibitory effect of Xiaoshui Formula on pleural effusion of lung cancer metastatic tumors in model mice［J］.China J Tradit Chin Med Pharm，2019，34（3）：956-960.
  59. 59.
    LI Y Y. Study on clinical and related mechanism of treating pain from bone metastases with Xiaozheng Zhitong gel ［D］.Beijing： China Academy of Chinese Medical Sciences，2022.
  60. 60.
    BAO Y J， HUA B J， HOU W， et al. Alleviation of cancerous pain by external compress with Xiaozheng Zhitong Paste［J］. Chin J Integr Med， 2010，16（4）：309-314.
  61. 61.
    SHI ZHAN，LU X G，LIU R，et al.Clinical observation on the efficacy of Xiaoshui decoction combined with Cisplatin in treating malignant pleural effusion［J］.China J Tradit Chin Med Pharm，2012，27（4）：1164-1166.
  62. 62.
    CHENG H B. Discussion on the pathogenesis theory of cancer toxin［J］.J Tradit Chin Med， 2014，55（20）：1711-1715.
  63. 63.
    TIAN J H， XI Y C，LUO B， et al. Scientific connotation of the theory of ''Strengthening vital Qi to treat cancer'' ［J］.Mod Tradit Chin Med Mater Medica-World Sci Technol，2019，21（5）：943-948.
  64. 64.
    LI Y Q，LI H Z，XU W， et al. Discussion on the academic thought of "survival with tumor"［J］.J Oncol Chin Med，2021，3（5）：6-10.
  65. 65.
    HUANG W Q， YANG B，WANG J H，et al. Analysis on LIU Shangyi's ''treatment from membrane， leading sore into tumor'' based on connection of ''sore'' and TCM tumor［J］.Liaoning J Tradit Chin Med，2024，51（1）：19-22.

Leer el texto completo

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website